Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference51 articles.
1. Carson DA, Wasson DB, Taetle R, Yu A. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 62(4), 737–743 (1983).
2. Sipe JC. Cladribine for multiple sclerosis: review and current status. Expert Rev. Neurother. 5(6), 721–727 (2005).
3. Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J, Beutler E. Cladribine in treatment of chronic progressive multiple sclerosis. Lancet. 344(8914), 9–13 (1994).
4. Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet. 340(8825), 952–956 (1992).
5. Rice GP, Filippi M, Comi G. Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group. Neurology. 54(5), 1145–1155 (2000).
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献